AMYOTROPHIC-LATERAL-SCLEROSIS IS A MULTIFACTORIAL DISEASE

被引:92
|
作者
EISEN, A [1 ]
机构
[1] UNIV BRITISH COLUMBIA, VANCOUVER, BC, CANADA
关键词
AMYOTROPHIC LATERAL SCLEROSIS; PATHOGENESIS; MULTIFACTORIAL; EXCITOTOXICITY; CORTICOMOTONEURON;
D O I
10.1002/mus.880180711
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Amyotrophic lateral sclerosis (ALS) is probably biphasic. An initial trigger(s) is followed by a terminal cascade coinciding with the onset of neurological deficits. The terminal cascade involves interactive multifactorial pathogenic mechanisms. Aging must play a crucial role leading to multiple defective or degraded gene products accumulating with progressing years. This in turn leads to failure of receptor integrity and resulting excitotoxicity, free radical accumulation, failure of neurotrophism, and possibly immunological disturbances. These events are predated by months or years by a trigger which is also likely to be multifactorial and cumulative. Evidence suggests that environmental factors may be important triggers. Failure of specific glutamate transporters and calcium binding proteins may account for selective vulnerability of the corticomotoneuronal system. It is postulated that in ALS the primary target cell is the corticomotoneuron or the local circuit interneurons which modulate its activity. Glia cells may play an important role in the demise of the corticomotoneuronal cell. The disordered corticomotoneuron induces excessive excitatory transmitter (glutamate?) release at the corticomotoneuronal-spinal-motoneuronal synapse resulting in the subsequent demise of this neuron. (C) 1995 John Wiley and Sons, Inc.
引用
收藏
页码:741 / 752
页数:12
相关论文
共 50 条
  • [1] AMYOTROPHIC-LATERAL-SCLEROSIS - A MULTIFACTORIAL DISEASE
    EISEN, AA
    [J]. PATHOGENESIS AND THERAPY OF AMYOTROPHIC LATERAL SCLEROSIS, 1995, 68 : 121 - 134
  • [2] AMYOTROPHIC-LATERAL-SCLEROSIS
    EISEN, A
    [J]. INTERNAL MEDICINE, 1995, 34 (09) : 824 - 832
  • [3] AMYOTROPHIC-LATERAL-SCLEROSIS
    MEININGER, V
    [J]. GAZETTE MEDICALE, 1991, 98 (04): : 39 - 42
  • [4] AMYOTROPHIC-LATERAL-SCLEROSIS
    ROWLAND, LP
    [J]. CURRENT OPINION IN NEUROLOGY, 1994, 7 (04) : 310 - 315
  • [5] AMYOTROPHIC-LATERAL-SCLEROSIS - AN AUTOIMMUNE-DISEASE
    DRACHMAN, DB
    FISHMAN, PS
    ROTHSTEIN, JD
    MOTOMURA, M
    LANG, B
    VINCENT, A
    MELLITS, ED
    [J]. PATHOGENESIS AND THERAPY OF AMYOTROPHIC LATERAL SCLEROSIS, 1995, 68 : 59 - 65
  • [6] A VARIETY OF AMYOTROPHIC-LATERAL-SCLEROSIS
    PROTAS, II
    DRAKIN, SA
    NEDZVED, MK
    MILKAMANOVICH, EK
    [J]. ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 1992, 92 (02): : 25 - 30
  • [7] NEUROPHARMACOLOGY OF AMYOTROPHIC-LATERAL-SCLEROSIS
    ASKMARK, H
    AQUILONIUS, SM
    GILLBERG, PG
    [J]. PROGRESS IN BRAIN RESEARCH, 1990, 84 : 371 - 380
  • [8] AMYOTROPHIC-LATERAL-SCLEROSIS AND PREGNANCY
    VINCENT, O
    RODRIGUEZITHURRALDE, D
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1995, 129 : 42 - 43
  • [9] ATYPICAL AMYOTROPHIC-LATERAL-SCLEROSIS
    BENHAMIDA, M
    HENTATI, F
    [J]. PATHOGENESIS AND THERAPY OF AMYOTROPHIC LATERAL SCLEROSIS, 1995, 68 : 153 - 155
  • [10] AMYOTROPHIC-LATERAL-SCLEROSIS AND AUTOIMMUNITY
    ROWLAND, LP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (24): : 1752 - 1753